Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Venture Catheter Recall Issued Over Reports of Tip Splitting, Separations June 22, 2017 Russell Maas Add Your Comments More than 7,000 catheters have been recalled due to a risk that excess material at the end of the tip of the catheter may separate during use, potentially resulting in serious adverse health consequences or death. A Vascular Solutions Venture catheter recall was announced by the FDA on June 21, after recognizing the potential for the catheters’ ends to break and separate during use, allowing excess materials to travel through veins or create blood clots, among various other injuries. The recall notice follows an Urgent Medical Device Recall letter that was sent to affected customers by Vascular Solutions Inc. on April 25, informing customers of the potential risk associated with the catheter tips breaking. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The catheters are intended for directing, steering, controlling and supporting a guidewire to access veins and arteries within the arms, legs, feet, hands, and heart muscle. Certain models are designed to also administer fluids or drugs into the patients’ blood vessels. In the event the catheter tips split or separate during use, excess material at the tip could enter the patient’s bloodstream, leading to adverse health consequences such as blood clots, embolism, damage to vital organs, or death. The recall includes Venture RX catheters with model number 5820, Venture OTW catheters with model number 5821, and Venture CS catheters with model number 5822. The devices were manufactured by Vascular Solutions Inc., from May 7, 2015 through March 31, 2017, where they were distributed for sale to healthcare facilities across the United States from May 7, 2015 through April 19, 2017. According to the FDA recall notice, an estimated 7,054 recalled Venture catheters were distributed for sale throughout the U.S. Vascular Solutions Inc., has initiated its notification process to inform affected customers and patients of the dangers associated with the catheters. Customers are being instructed to identify and remove any recalled Venture catheters from their inventory and to contact Vascular Solutions at 1-888-240-6001 or email them at customerservice@vasc.com for information on how to receive a free credit. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Blood Clot, Catheter, Catheter Recall, Medical Device Recall More Lawsuit Stories Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026 Judge Clears DraftKings Lawsuit Over Deceptive Practices To Move Forward February 20, 2026 Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: yesterday) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026) MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 2 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026) $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 3 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit February 20, 2026
Processed Food Type 2 Diabetes Lawsuit Alleges Companies Targeted Children With Toxic, Addictive Ingredients February 20, 2026
Depo-Provera Brain Tumor Risks Make Birth Control Shot Unreasonably Dangerous: Lawsuit (Posted: yesterday) A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Indicates Depo-Provera Meningioma Lawsuits Should Be Preempted by Federal Law (02/03/2026)Proposed Depo-Provera Lawsuit Schedule Calls for First Trial in Dec. 2026 (01/23/2026)Lawsuit Indicates Depo-Provera Meningioma Diagnosis Followed Memory Loss, Dizziness Symptoms (01/20/2026)
MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (Posted: 2 days ago) A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims. MORE ABOUT: DUPIXENT LAWSUITLawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks (02/03/2026)Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (01/12/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits (Posted: 3 days ago) Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed. MORE ABOUT: ROUNDUP LAWSUITSRoundup Settlement Program Remains Option With Supreme Court Review Pending: MDL Judge (02/09/2026)Future of Roundup Lawsuits Over Non-Hodgkin’s Lymphoma To Be Decided by U.S. Supreme Court (01/19/2026)Roundup Safety Study Retracted Decades After Publication (12/08/2025)